A volunteer on a possible vaccine trial for Corona virus revealed that the dose he had left left him in a severe illness he had not seen throughout his life, but he was still "cautiously optimistic" about the drug's potential.
Ian Haydon, 29, a communications director based in Seattle, said he started feeling chills within hours of returning home after taking his second dose - as well as waking up in the early hours with a fever of 39.56 ° C.
Ian was already nauseous and suffered from muscle pain, so his girlfriend called a 24-hour hotline, set up by those who lead the study, following their advice to go to urgent care, he told the New York Post and the BBC. BBC".
After sleeping for a few hours, his temperature was still 38.61 degrees Celsius and he felt nauseous in his bathroom, then he fainted while on his way back to the bedroom. Fortunately, he was with his girlfriend to prevent his head from hitting the ground.
He called the doctors supervising the study for the second time, and finally decided to stay home and rest, with the fever eventually diminishing that night.
In a series of tweets on "Twitter", he expressed his concern about revealing the horror he suffered, because he was wary of "stirring up anti-vaccination people." "I understand that sharing the story will be scary for some people," he said. "I hope it will not stoke any kind of public hostility towards vaccines in general or even this vaccine."
He stressed that he got the highest dose of experiments - 10 times stronger than others - which he was told "will not be tested anymore."
He insisted: "There is no failure here - which is a great reason to conduct clinical trials. Even safe medicines cannot be taken in 10-fold doses." He also said that his medical condition was never "life threatening".
The study, conducted with the National Institute of Allergy and Infectious Diseases, tested 45 patients between the ages of 18 and 55. Initial results showed that the drug created levels of antibodies equal to or greater than those in patients who recovered from "Covid-19".

Follow our latest local and sports news and the latest political and economic developments via Google news